Stay updated with breaking news from Codexis Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Victory Capital Management Inc. grew its position in shares of Codexis, Inc. (NASDAQ:CDXS – Get Rating) by 12.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,737,309 shares of the biotechnology company’s stock after acquiring an additional 198,713 shares during the quarter. Victory […]
Dr. Stephen Dilly, Board member and biotechnology veteran, named the next President and CEOJohn Nicols to retire after ten years leading the transformation and growth of Codexis REDWOOD CITY,... | July 18, 2022
Codexis, Inc. (NASDAQ:CDXS – Get Rating) has received an average recommendation of “Moderate Buy” from the seven research firms that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation and three have assigned a buy recommendation to the company. The average twelve-month target price among […]
Dublin, July 15, 2022 (GLOBE NEWSWIRE) -- The "Synthetic Biology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027"...
(RTTNews) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 06.55 A.M. ET). In the Green United Mar...